Gene · 407053
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating an entropy-driven DNA circuit with a tetrahedral scaffold as a generic in situ electrochemical biosensor for amplified detection of microRNAs. | Analyst | 2025 | 39925032 | PubTator, text mining | PubMed |
| MicroRNA‑96 promotes the proliferation and migration of breast cancer cells by inhibiting Smad7 expression. | Oncol Lett | 2025 | 39898288 | PubTator, text mining | PubMed |
| Color-Coded Traffic Signal Method Combined with Nanodiamond Quantum Sensing for Accurate miRNA Detection. | ACS Sens | 2025 | 39714924 | PubTator, text mining | PubMed |
| Multiple Myeloma: Genetic and Epigenetic Biomarkers with Clinical Potential. | Int J Mol Sci | 2024 | 39769169 | PubTator, text mining | PubMed |
| MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis. | Int J Mol Sci | 2024 | 39684593 | PubTator, text mining | PubMed |
| Comprehensive Analysis of circRNA-Related mRNAs as Prognostic Factors in Non-Smoking Women with Lung Adenocarcinoma. | Int J Gen Med | 2024 | 39650787 | PubTator, text mining | PubMed |
| Messing up with the regulator: A rational AI-driven drug design strategy to disrupt miRNA-target interactions. | Mol Ther Nucleic Acids | 2024 | 39497811 | PubTator, text mining | PubMed |
| MicroRNA and Rare Human Diseases. | Genes (Basel) | 2024 | 39457367 | PubTator, text mining | PubMed |
| Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human MIR96 mutations. | Genome Med | 2024 | 39434156 | PubTator, text mining | PubMed |
| Characterization of small RNAs in the spleen of MASH in a non-human primate model. | Genomics | 2024 | 39419194 | PubTator, text mining | PubMed |
| Crosstalk between MIR-96 and IRS/PI3K/AKT/VEGF cascade in hRPE cells; A potential target for preventing diabetic retinopathy. | PLoS One | 2024 | 39348384 | PubTator, text mining | PubMed |
| Suppression of neuronal CDK9/p53/VDAC signaling provides bioenergetic support and improves post-stroke neuropsychiatric outcomes. | Cell Mol Life Sci | 2024 | 39235466 | PubTator, text mining | PubMed |
| Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC). | Br J Cancer | 2024 | 39215192 | PubTator, text mining | PubMed |
| A new perspective on microRNA-guided gene regulation specificity, and its potential generalization to transcription factors and RNA-binding proteins. | Nucleic Acids Res | 2024 | 39149906 | PubTator, text mining | PubMed |
| Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer. | Comput Biol Med | 2024 | 39142223 | PubTator, text mining | PubMed |
| CmirC update 2024: a multi-omics database for clustered miRNAs. | Funct Integr Genomics | 2024 | 39085735 | PubTator, text mining | PubMed |
| Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. | Sci Transl Med | 2024 | 38985856 | PubTator, text mining | PubMed |
| A cell type-specific approach to elucidate the role of miR-96 in inner ear hair cells. | Front Audiol Otol | 2024 | 38826689 | PubTator, text mining | PubMed |
| Unraveling the role of microRNAs: potential biomarkers for gestational diabetes mellitus revealed through RNA sequencing analysis. | Arch Gynecol Obstet | 2024 | 38814453 | PubTator, text mining | PubMed |
| microRNA and the Post-Transcriptional Response to Oxidative Stress during Neuronal Differentiation: Implications for Neurodevelopmental and Psychiatric Disorders. | Life (Basel) | 2024 | 38792584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407053/papers?page=3